<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wisby L</submitter><funding>Medical Research Council</funding><pagination>242</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3751763</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Streptococcus pneumoniae causes over one million deaths worldwide annually, despite recent developments in vaccine and antibiotic therapy. Host susceptibility to pneumococcal infection and disease is controlled by a combination of genetic and environmental influences, but current knowledge remains limited.&lt;h4>Results&lt;/h4>In order to identify novel host genetic variants as predictive risk factors or as potential targets for prophylaxis, we have looked for quantitative trait loci in a mouse model of invasive pneumococcal disease. We describe a novel locus, called Streptococcus pneumoniae infection resistance 2 (Spir2) on Chr4, which influences time to morbidity and the development of bacteraemia post-infection.&lt;h4>Conclusions&lt;/h4>The two quantitative trait loci we have ide</pubmed_abstract><journal>BMC genomics</journal><pubmed_title>Spir2; a novel QTL on chromosome 4 contributes to susceptibility to pneumococcal infection in mice.</pubmed_title><pmcid>PMC3751763</pmcid><funding_grant_id>G0501416</funding_grant_id><funding_grant_id>MC_U142684174</funding_grant_id><pubmed_authors>Kadioglu A</pubmed_authors><pubmed_authors>Fernandes VE</pubmed_authors><pubmed_authors>Andrew PW</pubmed_authors><pubmed_authors>Wisby L</pubmed_authors><pubmed_authors>Denny P</pubmed_authors><pubmed_authors>Neill DR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Spir2; a novel QTL on chromosome 4 contributes to susceptibility to pneumococcal infection in mice.</name><description>&lt;h4>Background&lt;/h4>Streptococcus pneumoniae causes over one million deaths worldwide annually, despite recent developments in vaccine and antibiotic therapy. Host susceptibility to pneumococcal infection and disease is controlled by a combination of genetic and environmental influences, but current knowledge remains limited.&lt;h4>Results&lt;/h4>In order to identify novel host genetic variants as predictive risk factors or as potential targets for prophylaxis, we have looked for quantitative trait loci in a mouse model of invasive pneumococcal disease. We describe a novel locus, called Streptococcus pneumoniae infection resistance 2 (Spir2) on Chr4, which influences time to morbidity and the development of bacteraemia post-infection.&lt;h4>Conclusions&lt;/h4>The two quantitative trait loci we have ide</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Apr</publication><modification>2026-05-06T21:38:23.656Z</modification><creation>2026-04-07T22:22:10.947Z</creation></dates><accession>S-EPMC3751763</accession><cross_references><pubmed>23577770</pubmed><doi>10.1186/1471-2164-14-242</doi></cross_references></HashMap>